Skip to search formSkip to main contentSkip to account menu

Trial Phase 3A

Known as: 3A, Phase IIIa Trial, Trial Phase IIIA 
A classification typically assigned retrospectively to a Phase III trial after regulatory authorities determined the need for a Phase III B trial.
National Institutes of Health

Related topics

Related topics

3 relations
CDISC SDTM Trial Phase TerminologyClinical Data Interchange Standards Consortium Terminology

Broader (1)

Research Activities

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
2011
2011
Patterning a spiralian embryo: a segregated RNA for a Tis11 ortholog is required in the 3a and 3b cells of the Ilyanassa embryo.
2011
2011
Promiscuous prediction and conservancy analysis of CTL binding epitopes of HCV 3a viral proteome from Punjab Pakistan: an In Silico Approach
BackgroundHCV is a positive sense RNA virus affecting approximately 180 million people world wide and about 10 million Pakistani… 
2011
2011
Response to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A protein
BackgroundHepatitis C virus (HCV) genotype 3a is known to show comparatively better response to combination therapy than genotype… 
2009
2009
Outcomes of a patient‐to‐patient outbreak of genotype 3a hepatitis C
Between March 2000 and July 2001, at least 99 persons acquired a hepatitis C virus genotype 3a (HCV‐3a) infection in an oncology… 
2003
2003
Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a.
The clinical correlation between the degree of HCV variability and the response to anti-HCV treatment in HIV positive patients… 
2000
2000
Hierarchy within human SI: supporting data from cytochrome oxidase, acetylcholinesterase and NADPH-diaphorase staining patterns
The human primary somatosensory cortex consists of four cytoarchitectonic subdivisions (3a, 3b, 1 and 2) that are likely to… 
1996
1996
Preferential virological response to interferon-alpha 2a in patients with chronic hepatitis C infected by virus genotype 3a and exhibiting a low gamma-GT/ALT ratio.
Hepatitis C virus infection causes acute and often chronic hepatitis. Therapy with interferon-alpha has been shown to induce… 
1996
1996
Preferential virological response to interferon-α2a in patients with chronic hepatitis C infected by virus genotype 3a and exhibiting a lowγ-GT/ALT ratio
Hepatitis C virus infection causes acute and often chronic hepatitis. Therapy with interferon-α has been shown to induce… 
1994
1994
Bladder conservation in selected T1G3 and muscle-invasive T2-T3a bladder carcinoma using combination therapy of surgery and iridium-192 implantation.
OBJECTIVE To retrospectively analyse the efficacy and toxicity of conservative treatment for T1G3 and T2-3a bladder carcinoma and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)